Table 1 Baseline demographic, clinical and laboratory data among the different studied groups.
Total (n = 403) | Iron sufficient group (n = 185) | NAID placebo group (n = 47) | NAID interventional group (n = 47) | IDA group (n = 124) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | No. | % | |
Gender | ||||||||||
Male | 203 | 50.4 | 98 | 53.0 | 22 | 46.8 | 23 | 48.9 | 60 | 48.4 |
Female | 200 | 49.6 | 87 | 47.0 | 25 | 53.2 | 24 | 51.1 | 64 | 51.6 |
Age (months) | ||||||||||
Mean ± SD. | 28.49 ± 16.15 | 29.48 ± 15.19 | 24.17 ± 14.31 | 26.34 ± 15.88 | 27.38 ± 16.44 | |||||
SES | ||||||||||
Low | 76 | 18.9 | 32 | 17.3 | 9 | 19.1 | 9 | 19.1 | 26 | 21.0 |
Middle | 287 | 71.2 | 138 | 74.6 | 33 | 70.2 | 33 | 70.2 | 83 | 66.9 |
High | 40 | 9.9 | 15 | 8.1 | 5 | 10.6 | 5 | 10.6 | 15 | 12.1 |
Birth weight (kg) | ||||||||||
Mean ± SD | 3.45 ± 0.50 | 3.45 ± 0.50 | 3.30 ± 0.50 | 3.46 ± 0.53 | 3.49 ± 0.49 | |||||
Gestational age (weeks) Mean ± SD. | 38.60 ± 1.04 | 38.65 ± 1.05 | 38.60 ± 1.01 | 38.57 ± 1.02 | 38.53 ± 1.03 | |||||
Hemoglobin (g/dl)(Mean ± SD) | 11.15 ± 1.18 | 11.91 ± 0.62 | 11.64 ± 0.27 | 11.67 ± 0.39 | 9.63 ± 0.75 | |||||
MCV (FL) (Mean ± SD) | 70.32 ± 13.35 | 83.68 ± 2.56 | 61.17 ± 6.65 | 61.23 ± 6.81 | 57.32 ± 6.10 | |||||
Ferritin (µg/L) Median (IQR) | 16.83 ± 12.57 | 24.0 (19.0–31.0) | 9.0 (7.50–10.0) | 8.0 (7.0–9.0) | 9.0 (7.0–10.0) | |||||
Developmental score (Mean ± SD) | 172 ± 27.63 | 201.3 ± 21.69 | 150.53 ± 24.39 | 151.9 ± 23.76 | 141.4 ± 27.02 | |||||
Weight for age Z score Median (IQR) | -0.89 ± 1.03 | -0.50 (-0.90–0.30) | -1.50 (-1.80– -0.90) | -1.50 (-1.75–-0.80) | -1.50 (-2.0– -1.0) | |||||
Length/height for age Z score Median (IQR) | -0.62 ± 0.99 | -0.40 (-0.90–0.50) | -1.10 (-1.55–-0.40) | -1.10 (-1.50–-0.40) | -1.15 (-1.60 –-0.40) | |||||
Weight for length or BMI for age Z score Median (IQR) | -0.92 ± 1.03 | -0.40 (-1.10–0.30) | -1.50 (-1.85–-0.80) | -1.40 (-1.90–-0.90) | -1.60 (-2.05– -1.0) | |||||
